Evidence map›Paper›PMID 39565297›Full record

ArticleHuman molecular genetics2025

De novo missense variants in the PP2A regulatory subunit PPP2R2B in a neurodevelopmental syndrome: potential links to mitochondrial dynamics and spinocerebellar ataxias.

Priyanka Sandal, Chian Ju Jong, Ronald A Merrill, Grace J Kollman, Austin H Paden, Eric G Bend, Jennifer Sullivan, Rebecca C Spillmann, Vandana Shashi, Anneke T Vulto-van Silfhout and 5 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Houge-Janssens syndrome.European journal of human genetics : EJHG · 2025
    Review
  6. The genetic architecture of fibromyalgia across 2.5 million individuals.medRxiv : the preprint server for health sciences · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Priyanka SandalDepartment of Neuroscience and Pharmacology, University of Iowa, Carver College of Medicine, Bowen Science Building, 51 Newton Road, Iowa City, IA 52242, United States.
Chian Ju JongDepartment of Neuroscience and Pharmacology, University of Iowa, Carver College of Medicine, Bowen Science Building, 51 Newton Road, Iowa City, IA 52242, United States.
Ronald A MerrillDepartment of Neuroscience and Pharmacology, University of Iowa, Carver College of Medicine, Bowen Science Building, 51 Newton Road, Iowa City, IA 52242, United States.
Grace J KollmanDepartment of Neuroscience and Pharmacology, University of Iowa, Carver College of Medicine, Bowen Science Building, 51 Newton Road, Iowa City, IA 52242, United States.
Austin H PadenDepartment of Neuroscience and Pharmacology, University of Iowa, Carver College of Medicine, Bowen Science Building, 51 Newton Road, Iowa City, IA 52242, United States.
Eric G BendPreventionGenetics, Part of Exact Sciences, 3800 S Business Park Ave, Marshfield, WI 54449, United States.
Jennifer SullivanDepartment of Pediatrics, University of North Carolina Chapel Hill, 260 MacNider Hall, CB# 7220, 333 South Columbia St., Chapel Hill, NC 27599-7220, United States.
Rebecca C SpillmannDepartment of Pediatrics - Medical Genetics, Duke University Medical Center, DUMC Box 103857, Durham, NC 27710, United States.
Vandana ShashiDepartment of Pediatrics - Medical Genetics, Duke University Medical Center, DUMC Box 103857, Durham, NC 27710, United States.
Anneke T Vulto-van SilfhoutDepartment of Clinical Genetics, Maastricht University Medical Center, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.
Rolph PfundtDepartment. of Human Genetics, Nijmegen Centre for Molecular Life Sciences and Institute for Genetic and Metabolic Disorders, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525 GA, the Netherlands.
Bert B A de VriesDepartment. of Human Genetics, Nijmegen Centre for Molecular Life Sciences and Institute for Genetic and Metabolic Disorders, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525 GA, the Netherlands.
Pan P LiDivision of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 600 N Wolfe St, CMSC 8-117, Baltimore, MD 21287, United States.
Louise S BicknellDepartment of Biochemistry, University of Otago, 710 Cumberland St., Dunedin North, Dunedin 9016, New Zealand.ORCID 0000-0001-6899-9322
Stefan StrackDepartment of Neuroscience and Pharmacology, University of Iowa, Carver College of Medicine, Bowen Science Building, 51 Newton Road, Iowa City, IA 52242, United States.ORCID 0000-0002-6175-7280

Funding

University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)P50HD103556 · NICHD · UNIVERSITY OF IOWA · PI EDWIN TED G. ABEL, Lane Strathearn · 2021 to 2026
$8.5M
Interplay between tau and PKA condensates in ADRDR21AG080472 · NIA · UNIVERSITY OF IOWA · PI STRACK, STEFAN, TAYLOR, SUSAN S. · 2023 to 2024
$559k
Ataxia Charlevoix-Saguenay FoundationNIA NIH HHS R21 AG080472NICHD NIH HHS P50 HD103556NIH HHS R21 AG080472-01Simons Foundation Autism Research Initiative
6 · The paper itself

Abstract

The heterotrimeric protein phosphatase 2A (PP2A) complex catalyzes about half of Ser/Thr dephosphorylations in eukaryotic cells. A CAG repeat expansion in the neuron-specific protein PP2A regulatory subunit PPP2R2B gene causes spinocerebellar ataxia type 12 (SCA12). We established five monoallelic missense variants in PPP2R2B (four confirmed as de novo) as a cause of intellectual disability with developmental delay (R149P, T246K, N310K, E37K, I427T). In addition to moderate to severe intellectual disability and developmental delay, affected individuals presented with seizures, microcephaly, aggression, hypotonia, as well as broad-based or stiff gait. We used biochemical and cellular assays, including a novel luciferase complementation assay to interrogate PP2A holoenzyme assembly and activity, as well as deregulated mitochondrial dynamics as possible pathogenic mechanisms. Cell-based assays documented impaired ability of PPP2R2B missense variants to incorporate into the PP2A holoenzyme, localize to mitochondria, induce fission of neuronal mitochondria, and dephosphorylate the mitochondrial fission enzyme dynamin-related protein 1. AlphaMissense-based pathogenicity prediction suggested that an additional seven unreported missense variants may be pathogenic. In conclusion, our studies identify loss-of-function at the PPP2R2B locus as the basis for syndromic intellectual disability with developmental delay. They also extend PPP2R2B-related pathologies from neurodegenerative (SCA12) to neurodevelopmental disorders and suggests that altered mitochondrial dynamics may contribute to mechanisms.

Indexed as

Mitochondrial DynamicsMutation, MissenseNeurodevelopmental DisordersProtein Phosphatase 2Spinocerebellar AtaxiasAdolescentChildChild, PreschoolDevelopmental DisabilitiesFemaleHumansIntellectual DisabilityMaleMitochondriaNerve Tissue ProteinsNerve Tissue ProteinsPPP2R2B protein, humanProtein Phosphatase 2cerebellar ataxiasdynamin-related protein 1mitochondrial dynamicsneurodevelopmental disordersprotein phosphatase 2A

Identifiers

PMID39565297
PMCPMC11780858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.